pstan3.17PS Tan (photo), aka lotustpsll, has been a shareholder of Best World International since 2015. He contributed this article to NextInsight. He worked with HSBC Group for over 30 years. Over the last 15 years of his  career he headed senior positions in the Risk Division of the Bank. His last post was Head of Risk Strategy. He was responsible for setting up two departments – Corporate Risk Identification and Financial Analysis – within Corporate Risk Division and managing them.

BWI released its annual results on 26 Feb. Last Q4 was a record quarter in many respects. 







Gross Profit



Net Op Profit






Free Cash Flow




5.12 c

13.26 c

The magnitude of Q4 numbers is immense in relation to the full-year results.

Overall, NPAT for FY18 rose 31.6% y-o-y to S$72.5 million, despite a decline of 30% for H1. Management's positive guidance for FY18 was met.

The incredibly strong Q4 should provide a foundation for a stronger performance this year.

Management is confident of better results and has provided a positive guidance for FY19.

Country performance, based on revenue generated, was impressive (see table):

Top markets





+31 %







China’s new franchise model is working well and we may expect a multi-year growth profile given the scale of this enormous market.

Initial signs are very encouraging and that the Management’s strategies and plans are being successfully executed. Shareholders believe BWI can replicate its Taiwan success story and to achieve more in China.

China will be the key market to watch this year. 

Stability in Taiwan’s market in 2018 is welcome news for shareholders as it enters into a more matured phase. No doubt, Taiwan will continue to be an important market. Hopefully, we see a high single-digit growth rate for FY19.

Management and shareholders are equally excited over the potential growth prospects of Indonesia, 4th most populous nation. The group is keen to develop and to expand on this market.

DRsSecret17DR's Secret: Various items in the DR’s Secret line were first introduced in 2001, 2002 and 2003. DR’s Secret is, thus, a time-tested product line that has proven to be successful. In a nutshell, we are witnessing a growing and wider acceptance of BWI’s products, notably DR's Secret. This augurs well for the Group.

Why BWL is such an attractive investment for many shareholders? This is a summary of the varied factors -- based on facts.

  • BWI is a 28 year old home-grown business (a rare breed), not an overnight MLM.

  • Extensive experience of key directors (who are Founders of BWI) in this industry.

  • Strong track record of business success through astute business planning and execution, for e.g. Taiwan, China and Indonesia.

  • Secular uptrend of demand for premium “skincare” products.

  • An “asset light” business model that can be replicated from country to country.

  • Taiwan’s success story – a “Best in Class” case study for corporate strategy, planning and execution.

  • Similar cultural profiles of both China and Taiwan consumers allow BWI to use the Taiwan’s success story to map out its business plans and strategies in China.

  • Strong revenue growth in China and Indonesia. Management will be keen to raise its market share.

  • Strong EBITDA margins exceeding 30% achieved for the past 7 QTRs. Indicative of a highly profitable business model. Not many public-listed companies can achieve such margins.

  • Strong financial position supported by current huge cash reserves of s$205 million. Liquidity is stable and strong. No inherent cash flow or balance sheet risk.

  • For FY18, BWI generated free cash flow of s$148 million. This represents a solid FCF yield of 11.5%. A strong cash-generative business that will strengthen its capital structure and instil financial flexibility to fund business expansions and investments. Also, provides options to reward shareholders and raise shareholder value.

  • BWI has won numerous awards over the years. Last November, BWI was recognised by Forbes Asia “200 Best Under a Million”. This annual award honours high-performing Asia-Pacific listed companies, selected from a pool of 24,000 companies with an annual revenue between $5 million and $1 billion. Only 3 Singapore companies made it to the list.

  • From FY15 to FY17, BWI grew its EBITDA from s$19.8 million to s$72.5 million. This golden period was driven notably by Taiwan’s business growth. A stunning CAGR of 54%. Can BWI repeat this sizzling run from FY18 to FY21? Management is confident of FY19 outlook. This is looking positive.

  • BWI has appointed Chester Fong as an Independent Director, a significant addition to further the success of the company’s China/HK strategy. This is a good and strategic appointment which Business Times overlooked. Instead, BT merely cited Chester as a replacement to an ID who had resigned, casting the resignation in a negative light along with the rest of the article. 

    To do justice to Chester, I highlight below his extensive experience in the corporate world:

  • Mr Fong is currently a part-time senior advisor at McKinsey in Asia-Pacific supporting Strategy and Corporate Finance with focus on transactions and CFO service lines. He has more than 30 years of experience in finance and general management at Colgate-Palmolive, a global consumer products company; He was the Chairman and CEO of Greater China and the Chief Financial Officer of Greater Asia. During his tenure with Colgate-Palmolive he has championed and supported many global and regional acquisition projects.” (Source: BWI website). 

watchnowKorean celebrity Chailee Son talks about DR's Secret: 

Projecting earnings growth

Although the China franchise model was adopted only in H2 2018, the company's FY18 EPS rose 31% y-o-y to 13.26c.

Let’s assume BWI can generate 40% CAGR on EPS, using FY18 EPS as the base. 



P/E ^

Stock price (P/E @ 18)

















^ based on recent price of $2.23

Further assume a conservative P/E of 18 for valuation purpose (even though I categorise BWI as a high growth stock that deserves a higher P/E rating).

The projected EPS and stock values are tabulated in the table.

Based on the projections, I believe the current share price represents a solid entry point for long term investors. BW is a quality high growth play with a 28-year operating history.

Also, bear in mind that BWL has invested in the stem cell business, currently holding a 12.5% stake in Celligenics Pte Ltd, which could provide a catalyst to its share price if this project comes to fruition.  This exciting investment certainly bears watching.

Please do your own due diligence before investing.

I have invested in BWI since 2015.


I find the BT article to be biased and unbalanced, which is extremely damaging to BWI, its shareholders and business partners. Article was damning with not a single positive point mentioned of BWL. The timing of release of the article is suspicious -- during a blackout period before the full-year results release when management had to refrain from commenting for a media article in order to avoid the risk of selectively disclosing non-public information.

I'm gratified that a fellow shareholder, Jason Wee, CFA, has given an objective rebuttal to BT's story

See PS Tan's previous article: 


0 #3 Buster 2019-03-11 13:37
I think it “ best”for Best world to publish the independent review before shareholders pitch in and support the company. By virtue of you being a shareholder there will be inherent bias in your view . There are many rumours circulating in the market about the unusual nature of the rise in best worlds price, some quite damning which could be seriously be detrimental to any one buying the stock. I think it’s best world’s duty to publish the review as soon as possible rather than garnering support from current shareholders . Independent reviews are always best in such circumstances .
0 #2 chong h s 2019-03-11 10:03
PS Tan, very much appreciate your comments and those of Jason Wee.

As an ex-fund manager myself always looking for good Singapore SMEs to support, I do
believe that Best World is really one of the best to have emerged over the last 5 years..and should be supported and cheered by not only the investment community but by all Singaporeans!

It is therefore completely uncalled for and quite insane for our only business journal to publish at best a half baked and at worst an almost slanderous article on BW at a sensitive time during their results period. It really looks suspicious to me and I think the authorities like SGX and CPIB should investigate this "incident" to make sure that there was no "foul play" at work.

For the record, I have been a shareholder since 2016.
0 #1 Obsever 2019-03-10 22:15
Grass roots support against media bullying.... great job and also that by Jason Wee in an earlier article.....

I have no stake in BW.... I felt poor journalistic standards was used in trying to write the BT article.. .... you don’t see these type of calibre of shareholders speaking out in other “problem” shares....

Share Prices

Counter NameLastChange
AEM Holdings2.090-0.140
Avi-Tech Electronics0.415-0.020
Best World Int.1.360-
China Sunsine0.445-
CNMC GoldMine0.2550.010
CSE Global0.550-0.015
Eagle HTrust USD0.470-0.050
Food Empire0.760-0.010
Golden Energy0.153-0.002
GSS Energy0.088-0.004
ISDN Holdings0.198-0.001
JB Foods0.625-0.030
KSH Holdings0.390-0.010
Moya Asia0.074-0.004
Nordic Group0.275-0.020
Oxley Holdings0.335-0.010
REX International0.178-0.015
Sing Holdings0.405-
Straco Corp.0.560-0.010
Sunningdale Tech1.240-0.020
Sunpower Group0.530-0.015
The Trendlines0.109-0.016
Tiong Seng0.200-
Uni-Asia Group0.685-0.010
Yangzijiang Shipbldg1.000-0.040

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 1031 guests and no members online